GlaxoSmithKline (GSK)
40.58
+0.25 +0.62%
NYSE
Sep 22, 09:25
Delayed 2m
USD
View All Key Stats
GSK Key Stats
| Income Statement | |
| Revenue (TTM) | 37.83B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 0.9957 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 2.446B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 64.22% |
| Profit Margin (Quarterly) | -2.46% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 4.98% |
| Price and Valuation | |
| Market Cap | 99.79B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 2.637 |
| PE Ratio (TTM) | 40.76 |
| Price to Book Value | 94.57 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 23.27 |
| Free Cash Flow (Quarterly) | 535.18M |
| Return on Equity (TTM) | 221.3% |
View All GSK News
GSK News
-
WireHeadlineTime (ET)
-
MT Newswires09/22 08:40
-
SA Breaking News09/21 16:18
-
Yahoo09/21 09:44
-
Yahoo09/21 08:33
-
MT Newswires09/21 08:19
-
MT Newswires09/21 07:49
-
Yahoo09/20 09:40
-
MT Newswires09/20 08:38
-
MT Newswires09/20 04:59
-
MT Newswires09/20 04:34
View All Events
GSK Events
| Date | Type | Description |
|---|---|---|
| 10/25/2017 | Earnings | GlaxoSmithKline PLC Third Quarter Earnings Results in 2017 |
| 08/09/2017 | Dividends | Amount: 0.4964, Declared Date: Jul 26 2017, Pay Date: Oct 12 2017 |
| 07/26/2017 | Earnings | GlaxoSmithKline PLC Second Quarter Earnings Results in 2017 |
| 05/10/2017 | Dividends | Amount: 0.4882, Declared Date: Apr 26 2017, Pay Date: Jul 13 2017 |
| 05/04/2017 | Misc | GlaxoSmithKline PLC Annual General Meeting in 2016 |
| 04/26/2017 | Earnings | GlaxoSmithKline PLC First Quarter Earnings Results in 2017 |
| 03/14/2017 | Misc | GlaxoSmithKline PLC Annual Report in 2016 |
| 02/22/2017 | Dividends | Amount: 0.5758, Declared Date: Feb 08 2017, Pay Date: Apr 16 2017 |
| 02/08/2017 | Earnings | GlaxoSmithKline PLC Fourth Quarter Earnings Results in 2016 |
| 11/02/2016 | Dividends | Amount: 0.4621, Declared Date: Oct 31 2016, Pay Date: Jan 12 2017 |
GSK Fundamentals
Income Statement View Statement
GSK Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
GSK One Page Reports
- One Page Report Download
GSK Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Target Price | |
| Price | 40.58 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.gsk.com
- Investor Relations URL: http://www.gsk.com/en-gb/investors/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Next Earnings Release: Oct. 25, 2017
- Last Earnings Release: Jul. 26, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Aug. 09, 2017
- Description: GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including respiratory and antiviral, vaccines, over-the-counter (OTC) medicines and health-related consumer products.
GSK Comparables
EditGSK Excel Add-In Codes
- Name: =YCI("GSK","name")
- Description: =YCI("GSK","description")
- Sector: =YCI("GSK","sector")
- Industry: =YCI("GSK","industry")
- Est. Current Fiscal Year End: =YCI("GSK","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other GSK Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- GSK Tweets Stocktwits
Advertisement
